Accuray EBITDA Margin 2010-2025 | ARAY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Accuray (ARAY) over the last 10 years. The current EBITDA margin for Accuray as of March 31, 2025 is .
| Accuray EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.47B | $0.02B | 3.87% |
| 2024-12-31 | $0.45B | $0.01B | 2.65% |
| 2024-09-30 | $0.44B | $0.00B | 0.90% |
| 2024-06-30 | $0.45B | $0.01B | 1.79% |
| 2024-03-31 | $0.43B | 0 | 0.00% |
| 2023-12-31 | $0.45B | $0.01B | 1.57% |
| 2023-09-30 | $0.46B | $0.01B | 2.86% |
| 2023-06-30 | $0.45B | $0.01B | 1.79% |
| 2023-03-31 | $0.44B | $0.01B | 2.51% |
| 2022-12-31 | $0.42B | $0.01B | 1.92% |
| 2022-09-30 | $0.42B | $0.01B | 2.39% |
| 2022-06-30 | $0.43B | $0.02B | 3.50% |
| 2022-03-31 | $0.43B | $0.02B | 3.95% |
| 2021-12-31 | $0.44B | $0.02B | 5.03% |
| 2021-09-30 | $0.42B | $0.03B | 6.22% |
| 2021-06-30 | $0.40B | $0.03B | 7.32% |
| 2021-03-31 | $0.38B | $0.03B | 8.16% |
| 2020-12-31 | $0.38B | $0.03B | 8.75% |
| 2020-09-30 | $0.38B | $0.03B | 8.18% |
| 2020-06-30 | $0.38B | $0.02B | 5.73% |
| 2020-03-31 | $0.41B | $0.02B | 5.42% |
| 2019-12-31 | $0.41B | $0.02B | 4.65% |
| 2019-09-30 | $0.41B | $0.01B | 3.16% |
| 2019-06-30 | $0.42B | $0.01B | 3.11% |
| 2019-03-31 | $0.42B | $0.01B | 2.65% |
| 2018-12-31 | $0.41B | $0.01B | 1.21% |
| 2018-09-30 | $0.41B | $0.01B | 1.22% |
| 2018-06-30 | $0.41B | $0.01B | 1.98% |
| 2018-03-31 | $0.40B | $0.01B | 2.98% |
| 2017-12-31 | $0.40B | $0.02B | 4.25% |
| 2017-09-30 | $0.39B | $0.02B | 3.87% |
| 2017-06-30 | $0.38B | $0.01B | 3.39% |
| 2017-03-31 | $0.37B | $0.01B | 1.36% |
| 2016-12-31 | $0.38B | $0.01B | 3.20% |
| 2016-09-30 | $0.40B | $0.02B | 4.29% |
| 2016-06-30 | $0.40B | $0.02B | 4.01% |
| 2016-03-31 | $0.41B | $0.02B | 4.43% |
| 2015-12-31 | $0.40B | $0.01B | 3.51% |
| 2015-09-30 | $0.39B | $0.01B | 2.84% |
| 2015-06-30 | $0.38B | $0.00B | 0.79% |
| 2015-03-31 | $0.38B | $0.00B | 0.00% |
| 2014-12-31 | $0.38B | $0.00B | -0.53% |
| 2014-09-30 | $0.38B | $0.00B | 0.27% |
| 2014-06-30 | $0.37B | $0.01B | 1.35% |
| 2014-03-31 | $0.35B | $0.00B | -0.57% |
| 2013-12-31 | $0.33B | $-0.03B | -7.95% |
| 2013-09-30 | $0.31B | $-0.05B | -15.11% |
| 2013-06-30 | $0.32B | $-0.05B | -17.03% |
| 2013-03-31 | $0.33B | $-0.05B | -15.92% |
| 2012-12-31 | $0.36B | $-0.04B | -10.71% |
| 2012-09-30 | $0.39B | $-0.02B | -5.10% |
| 2012-06-30 | $0.41B | $-0.02B | -5.62% |
| 2012-03-31 | $0.38B | $-0.04B | -10.44% |
| 2011-12-31 | $0.34B | $-0.03B | -10.12% |
| 2011-09-30 | $0.28B | $-0.03B | -11.27% |
| 2011-06-30 | $0.22B | $-0.02B | -9.46% |
| 2011-03-31 | $0.21B | $0.01B | 4.31% |
| 2010-12-31 | $0.21B | $0.01B | 5.83% |
| 2010-09-30 | $0.21B | $0.01B | 3.35% |
| 2010-06-30 | $0.22B | $0.01B | 4.50% |
| 2010-03-31 | $0.22B | $0.00B | 1.83% |
| 2009-12-31 | $0.23B | $0.00B | 1.32% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.146B | $0.447B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $195.148B | 85.47 |
| Thermo Fisher Scientific (TMO) | United States | $162.069B | 19.60 |
| Edwards Lifesciences (EW) | United States | $45.045B | 29.53 |
| IDEXX Laboratories (IDXX) | United States | $43.992B | 50.56 |
| Alcon (ALC) | Switzerland | $43.297B | 29.26 |
| DexCom (DXCM) | United States | $32.517B | 50.26 |
| IQVIA Holdings (IQV) | United States | $28.414B | 15.91 |
| Mettler-Toledo (MTD) | United States | $25.128B | 29.88 |
| STERIS (STE) | Ireland | $23.368B | 25.74 |
| Waters (WAT) | United States | $20.841B | 29.41 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.678B | 0.00 |
| Hologic (HOLX) | United States | $14.436B | 15.69 |
| Sysmex ADR (SSMXY) | Japan | $10.859B | 30.80 |
| Penumbra (PEN) | United States | $9.723B | 76.31 |
| Masimo (MASI) | United States | $9.086B | 33.51 |
| Globus Medical (GMED) | United States | $8.010B | 19.09 |
| Glaukos (GKOS) | United States | $5.914B | 0.00 |
| Teleflex (TFX) | United States | $5.298B | 8.75 |
| TransMedics (TMDX) | United States | $4.370B | 94.99 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| PROCEPT BioRobotics (PRCT) | United States | $3.205B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.515B | 14.98 |
| Nihon Kohden (NHNKY) | Japan | $2.346B | 26.90 |
| Veracyte (VCYT) | United States | $2.154B | 30.23 |
| Elekta AB (EKTAY) | Sweden | $1.991B | 17.90 |
| Alphatec Holdings (ATEC) | United States | $1.606B | 0.00 |
| Artivion (AORT) | United States | $1.312B | 122.88 |
| Tandem Diabetes Care (TNDM) | United States | $1.118B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.048B | 5.57 |
| Pulse Biosciences (PLSE) | United States | $1.029B | 0.00 |
| SiBone (SIBN) | United States | $0.787B | 0.00 |
| IRadimed (IRMD) | United States | $0.786B | 39.87 |
| Beta Bionics (BBNX) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.571B | 8.88 |
| Mesa Laboratories (MLAB) | United States | $0.564B | 13.22 |
| OrthoPediatrics (KIDS) | United States | $0.546B | 0.00 |
| RxSight (RXST) | United States | $0.530B | 0.00 |
| AxoGen (AXGN) | United States | $0.498B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.480B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.451B | 12.00 |
| Delcath Systems (DCTH) | United States | $0.442B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.436B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.389B | 0.00 |
| NeuroPace (NPCE) | United States | $0.341B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.327B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.284B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.269B | 0.00 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.27 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Inogen (INGN) | United States | $0.201B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.159B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.60 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.11 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.026B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.07 |